{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:11:22Z","timestamp":1648710682658},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/grf.0b013e31827af708","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T17:30:46Z","timestamp":1357839046000},"page":"17-24","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Utility of HPV Testing"],"prefix":"10.1097","volume":"56","author":[{"given":"RAYMOND","family":"LUI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","article-title":"International incidence rates of invasive cervical cancer before cytological screening.","volume":"71","author":"Gustaffsson","year":"1997","journal-title":"Int J Cancer"},{"key":"R2-5-20210126","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening.","volume":"8","author":"Gustaffsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"R3-5-20210126","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0029-7844(95)00063-W","article-title":"The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.","volume":"85","author":"Nieminen","year":"1995","journal-title":"Obstet Gynecol"},{"key":"R5-5-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R6-5-20210126","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U. S. Preventive Services Task Force.","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"key":"R7-5-20210126","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R9-5-20210126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of HPV types associated with cervical cancer.","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"R10-5-20210126","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papilloma virus infections and type specific implications in cervical neoplasia.","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"key":"R11-5-20210126","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.","volume":"63","author":"Munger","year":"1989","journal-title":"J Virol"},{"key":"R13-5-20210126","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1073\/pnas.91.10.4382","article-title":"Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.","volume":"91","author":"Demers","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-5-20210126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the prevention and early detection of cervical cancer.","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R15-5-20210126","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods and baseline results.","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R16-5-20210126","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.03.056","article-title":"Genotyping of human papillomavirus in triaging of low-grade cervical cytology.","volume":"205","author":"Soderlund-Strand","year":"2011","journal-title":"Am J Obstet Gynecolo"},{"key":"R18-5-20210126","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","article-title":"Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"key":"R19-5-20210126","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/01.AOG.0000263461.71732.40","article-title":"Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.","volume":"109","author":"Safaeian","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R20-5-20210126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"R21-5-20210126","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"R22-5-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States.","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"R23-5-20210126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"R24-5-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized clinical trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R25-5-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00006250-200305000-00043","article-title":"Screening interval and risk of invasive squamous cell cervical cancer.","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R26-5-20210126","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.168.17.1881","article-title":"Trade-offs in cervical cancer prevention: balancing benefits and risks.","volume":"168","author":"Stout","year":"2008","journal-title":"Arch Intern Med"},{"key":"R27-5-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R28-5-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications of clinical focus on persistent infections.","volume":"100","author":"Rodrigues","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R29-5-20210126","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R30-5-20210126","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period.","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res"},{"key":"R31-5-20210126","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R32-5-20210126","first-page":"266","article-title":"Atypical glandular cells of undetermined significance. Histologic findings and proposed management.","volume":"47","author":"Hammoud","year":"2002","journal-title":"J Reprod Med"},{"key":"R33-5-20210126","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix.","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int J Cancer"},{"key":"R34-5-20210126","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","article-title":"Incidence trends of adenocarcinoma of the cervix in 13 European countries.","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R35-5-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/AOG.0b013e3181c799a3","article-title":"Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.","volume":"115","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R36-5-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.","volume":"11","author":"Wright","year":"2007","journal-title":"J Lower Genit Tract Dis"},{"key":"R37-5-20210126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for post treatment cervical intraepithelial neoplasia grade 2 or 3 disease.","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R38-5-20210126","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"R39-5-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA Testing with cytology triage andor repeat HPV DNA testing in primary cervical cancer screening.","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R40-5-20210126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer.","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R41-5-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/AJCP3CD9YKYFJDQL","article-title":"The sensitivity and specificity of p16(INK4a) cytology vs. HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL Pap cytology results.","volume":"134","author":"Denton","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R42-5-20210126","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1438.2007.01113.x","article-title":"The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.","volume":"18","author":"Kitchener","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R43-5-20210126","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1471-0528.2009.02263.x","article-title":"After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial.","volume":"116","author":"Sharp","year":"2009","journal-title":"BJOG"},{"key":"R44-5-20210126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"R46-5-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0b013e3182210034","article-title":"Low-risk human papillomavirus testing and other non- recommended human papillomavirus testing practices among U.S. health care providers.","volume":"118","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R47-5-20210126","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer.","volume":"197","author":"Castle","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R48-5-20210126","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1470-2045(09)70253-0","article-title":"Risk estimation for next generation of prevention programs for cervical cancer.","volume":"10","author":"Katki","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201303000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T18:20:08Z","timestamp":1644085208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201303000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e31827af708","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}